Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
2. Collegium Pharmaceutical, Inc.
14.4% sales growth and 19.57% return on equity
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.
Collegium Pharmaceutical, Inc.'s sales growth this year is expected to be 9.5% and 10.8% for next year.
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 310.02M for the twelve trailing months.
Collegium Pharmaceutical, Inc.'s sales growth for the next quarter is 14.4%. The company's growth estimates for the present quarter and the next is 2900% and 60.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.57%.
Volatility
Collegium Pharmaceutical, Inc.'s last day, last week, and last month's current volatility was 0.43%, 0.97%, and 1.56%, respectively.
Collegium Pharmaceutical, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.31% (day), 4.87% (last week), and 4.44% (last month), respectively.
Collegium Pharmaceutical, Inc.'s Stock Yearly Top and Bottom Value
Collegium Pharmaceutical, Inc.'s stock is valued at $23.25 at 23:22 EST, way below its 52-week high of $26.91 and way higher than its 52-week low of $15.66.
Collegium Pharmaceutical, Inc.'s Moving Average
Collegium Pharmaceutical, Inc.'s worth is under its 50-day moving average of $23.88 and above its 200-day moving average of $21.80.3. Invesco
20.2% sales growth and 5.43% return on equity
Invesco Ltd.
Invesco's sales growth this year is expected to be 11.6% and 5.9% for next year.
Year-on-year quarterly revenue growth declined by 6.5%, now sitting on 6.15B for the twelve trailing months.
Invesco's sales growth for the next quarter is 20.2%. The company's growth estimates for the present quarter and the next is 82.4% and 88.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.43%.
Volatility
Invesco's last day, last week, and last month's current volatility was 3.19%, 2.19%, and 1.77%, respectively.
Invesco's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.22% (day), 3.03% (last week), and 2.86% (last month), respectively.
Invesco's Stock Yearly Top and Bottom Value
Invesco's stock is valued at $26.53 at 23:22 EST, under its 52-week high of $26.90 and way higher than its 52-week low of $6.38.
Invesco's Moving Average
Invesco's worth is way above its 50-day moving average of $24.11 and way higher than its 200-day moving average of $18.34.Previous days news about Invesco
Fidelity, invesco look to buy into India’s virus-led stock slump. According to Bloomberg Quint on Friday, 23 April, "While there's no denying that the outbreak and its financial and humanitarian implications remain the key focus for market watchers, some long-term investors from Fidelity International and Invesco are already seeking opportunities to add stocks. "
According to Bloomberg Quint on Friday, 23 April, "The $161 billion Invesco QQQ Trust Series 1 exchange-traded fund (ticker QQQ) has bled nearly $6 billion over the past five days in its worst stretch since the dot-com era of 2000, according to data compiled by Bloomberg. "
According to Bloomberg Quint on Monday, 26 April, "He suggested buying small-cap stocks, energy shares and the Invesco S&P 500 High Beta exchange-traded fund."
According to Bloomberg Quint on Monday, 26 April, "Investors pulled $8.7 billion from the $357 billion SPDR S&P 500 ETF Trust (ticker SPY) last week -- the most since September -- while the $164 billion Invesco QQQ Trust Series 1 (ticker QQQ) posted weekly outflows of $2.6 billion."